Filing Flows › Agios Pharmaceuticals (AGIO) › How it makes money
How Agios Pharmaceuticals (AGIO) makes money
Agios Pharmaceuticals (AGIO) made $55.4M of revenue in the third quarter 2026 (Q3 2026), +330% from a year earlier.
Drawing the Sankey…
Where each dollar of revenue goes
| Line | Q3 2026 | % of revenue |
|---|---|---|
| Revenue | $55.4M | 100.0% |
Revenue, quarter by quarter
| Quarter | Revenue | Y/Y |
|---|---|---|
| Q3 2026 | $55.4M | +330% |
| Q2 2026 | $44.7M | +259% |
| Q1 2026 | $20.7M | +138% |
| Q4 2025 | $20.0M | +86% |
| Q3 2025 | $12.9M | +44% |
| Q2 2025 | $12.5M | +45% |
| Q1 2025 | $8.7M | +7% |
From Agios Pharmaceuticals' 10-Q filed Nov 5, 2026 (on EDGAR).
Questions
How does Agios Pharmaceuticals make money?
Agios Pharmaceuticals (AGIO) made $55.4M of revenue in the third quarter 2026 (Q3 2026), +330% from a year earlier.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.